PACT - Public Activities Coordination Tool
PACT - Public Activities Coordination Tool
PACT - Public Activities Coordination Tool
The public activities coordination tool (PACT) provides an overview of the substance-specific activities that authorities are working on under REACH and the CLP Regulation. These activities are being carried out in line with ECHA’s Integrated Regulatory Strategy.
PACT provides up-to-date information on the activities planned, ongoing or completed by ECHA and/or MSCAs for a given substance in the following areas:
- Data generation and assessment – dossier evaluation, substance evaluation, informal hazard assessment (PBT/vPvB/ED).
- Assessment of regulatory needs (ARN).
- Regulatory risk management – harmonised classification and labelling (CLH) , SVHC identification, recommendations for inclusion in the Authorisation List, restriction.
A summary of all the substance-specific activities can be found under ‘Details’ for each entry.
Further information
- Understanding PACT
- Integrated Regulatory Strategy
- Substances of potential concern
- Dossier Evaluation status
- Substance evaluation
- Endocrine disruptor assessment
- PBT assessment
- Assessment of regulatory needs list
- Registry of CLH intentions until outcome
- Registry of SVHC intentions until outcome
- Recommendations for inclusion in the Authorisation list
- Registry of restriction intentions until outcome
Filter the list
The List does not contain any Substances.
| Data generation and assessment | ARN | Regulatory risk management | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Glutaral | 203-856-5 | 111-30-8 | - | - | - | - | 1 | 1 | 1 | 1 | - | Details |
| Geraniol | 203-377-1 | 106-24-1 | - | - | 4 | 1 | - | 1 | - | - | - | Details |
|
Garlic, ext.
Extractives and their physically modified derivatives such as tinctures, concretes, absolutes, essential oils, oleoresins, terpenes, terpene-free fractions, distillates, residues, etc., obtained from Allium sativum, Liliaceae.
|
232-371-1 | 8008-99-9 | - | - | - | - | - | 1 | - | - | - | Details |
| Gallium arsenide | 215-114-8 | 1303-00-0 | - | - | 1 | - | - | 1 | - | - | - | Details |
| Fuberidazole | 223-404-0 | 3878-19-1 | - | - | - | - | - | 1 | - | - | - | Details |
| Formic acid | 200-579-1 | 64-18-6 | - | - | 1 | 1 | 1 | 1 | - | - | - | Details |
| foramsulfuron (ISO); 2-{[(4,6-dimethoxypyrimidin-2-yl)carbamoyl]sulfamoyl}-4-formamido-N,N-dimethylbenzamide; 1-(4,6-dimethoxypyrimidin-2-yl)-3-(2-dimethylcarbamoyl-5-formamidophenylsulfonyl)urea | 605-666-1 | 173159-57-4 | - | - | - | - | - | 1 | - | - | - | Details |
| Fluxapyroxad | 620-041-3 | 907204-31-3 | - | - | - | - | - | 1 | - | - | - | Details |
| flutolanil (ISO); N-[3-(propan-2-yloxy)phenyl]-2-(trifluoromethyl)benzamide; α,α,α-trifluoro-3′-isopropoxy-o-toluanilide | 613-921-3 | 66332-96-5 | - | - | - | - | - | 1 | - | - | - | Details |
| flutianil (ISO); (2Z)-{[2-fluoro-5-(trifluoromethyl)phenyl]thio}[3-(2-methoxyphenyl)-1,3-thiazolidin-2-ylidene]acetonitrile | 812-888-4 | 958647-10-4 | - | - | - | - | - | 1 | - | - | - | Details |